Emerging Infectious Diseases (Jun 2023)
MERS-CoV‒Specific T-Cell Responses in Camels after Single MVA-MERS-S Vaccination
Abstract
We developed an ELISPOT assay for evaluating Middle East respiratory syndrome coronavirus (MERS-CoV)‒specific T-cell responses in dromedary camels. After single modified vaccinia virus Ankara-MERS-S vaccination, seropositive camels showed increased levels of MERS-CoV‒specific T cells and antibodies, indicating suitability of camel vaccinations in disease-endemic areas as a promising approach to control infection.
Keywords